Phase 2 Crohn's Disease and Colitis Trial, Recruiting NCT04010526 Sponsor: Assistance Publique Hopitaux De Marseille Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 2 Crohn's Disease and Colitis Trial, Recruiting

NCT04010526
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Crohn's Disease for at least 6 months, confirmed through accepted clinical, imaging, or laboratory methods
  • People who have complex perianal fistulas (tunnels near the anal area) that have not responded to previous treatments, confirmed by examination under anaesthesia and MRI scan
  • People whose Crohn's Disease in the gut itself is either not active or only mildly active, based on a standard disease activity score (CDAI of 220 or below)
  • People aged 18 or older, of any sex
  • People who are in generally good health based on their medical history and a physical check-up
  • Women who could become pregnant must have a negative pregnancy test before joining; all participants who could father or become pregnant must use appropriate contraception as directed by the trial team

Who may not be able to join:

  • People whose Crohn's Disease in the gut is currently active and needs immediate treatment
  • People with a CDAI score above 220 (a measure showing more active gut disease)
  • People who have never received any treatment specifically for perianal fistulas related to Crohn's Disease
  • People with an abscess or fluid collection larger than 2 cm that has not been resolved beforehand
  • People with narrowing of the rectum or anal area that would prevent surgery
  • People currently taking steroid medications, or who have taken them in the last 4 weeks
  • People with a current or past cancer diagnosis of any kind, including cancer of a fistula
  • People with serious, uncontrolled conditions affecting the liver, blood, stomach or intestines (other than Crohn's), hormones, lungs, heart, nerves, or mental health
  • People with immune system conditions, whether present from birth or developed later in life
  • People with an allergy or medical reason they cannot receive local anaesthetic or the contrast dye used in MRI scans
  • People who are unable to have an MRI scan, for example due to having a pacemaker, certain metal implants, or severe claustrophobia
  • Women who are pregnant or breastfeeding
  • People who cannot safely undergo anaesthesia or surgery for any reason
  • People with a BMI below 18, as the procedure requires enough body fat tissue to be safely collected
  • People with certain active viral infections, including HIV, HTLV I and II, Hepatitis B, Hepatitis C, or Syphilis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: EMILIE GARRIDO PRADALIE, APHM

Phone: +33491368739

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
19 February 2020
Est. completion
1 July 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

clinically evaluated; Magnetic resonance imaging (MRI); Magnetic resonance imaging (MRI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov